337 related articles for article (PubMed ID: 9973378)
21. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.
Bianchi M; Meng C; Ivashkiv LB
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9573-8. PubMed ID: 10920190
[TBL] [Abstract][Full Text] [Related]
22. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes.
Minty A; Asselin S; Bensussan A; Shire D; Vita N; Vyakarnam A; Wijdenes J; Ferrara P; Caput D
Eur Cytokine Netw; 1997 Jun; 8(2):203-13. PubMed ID: 9262969
[TBL] [Abstract][Full Text] [Related]
23. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
[TBL] [Abstract][Full Text] [Related]
24. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.
Bingisser RM; Tilbrook PA; Holt PG; Kees UR
J Immunol; 1998 Jun; 160(12):5729-34. PubMed ID: 9637481
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor.
Moon JJ; Nelson BH
J Immunol; 2001 Sep; 167(5):2714-23. PubMed ID: 11509615
[TBL] [Abstract][Full Text] [Related]
26. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice.
Matsumoto A; Seki Y; Kubo M; Ohtsuka S; Suzuki A; Hayashi I; Tsuji K; Nakahata T; Okabe M; Yamada S; Yoshimura A
Mol Cell Biol; 1999 Sep; 19(9):6396-407. PubMed ID: 10454585
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules.
Chida D; Wakao H; Yoshimura A; Miyajima A
Mol Endocrinol; 1998 Nov; 12(11):1792-806. PubMed ID: 9817603
[TBL] [Abstract][Full Text] [Related]
28. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells.
Caldenhoven E; van Dijk TB; Tijmensen A; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
Stem Cells; 1998; 16(6):397-403. PubMed ID: 9831865
[TBL] [Abstract][Full Text] [Related]
29. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.
Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P
Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929
[TBL] [Abstract][Full Text] [Related]
30. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
32. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
Lischke A; Moriggl R; Brändlein S; Berchtold S; Kammer W; Sebald W; Groner B; Liu X; Hennighausen L; Friedrich K
J Biol Chem; 1998 Nov; 273(47):31222-9. PubMed ID: 9813029
[TBL] [Abstract][Full Text] [Related]
33. STAT5 involvement in the differentiation response of primary chicken myeloid progenitor cells to chicken myelomonocytic growth factor.
Woldman I; Mellitzer G; Kieslinger M; Buchhart D; Meinke A; Beug H; Decker T
J Immunol; 1997 Jul; 159(2):877-86. PubMed ID: 9218607
[TBL] [Abstract][Full Text] [Related]
34. Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations.
Fujii H; Ogasawara K; Otsuka H; Suzuki M; Yamamura K; Yokochi T; Miyazaki T; Suzuki H; Mak TW; Taki S; Taniguchi T
EMBO J; 1998 Nov; 17(22):6551-7. PubMed ID: 9822600
[TBL] [Abstract][Full Text] [Related]
35. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
[TBL] [Abstract][Full Text] [Related]
36. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
37. IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes.
Xue HH; Kovanen PE; Pise-Masison CA; Berg M; Radovich MF; Brady JN; Leonard WJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13759-64. PubMed ID: 12354940
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
39. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
40. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]